CDSCO approves Wockhardt’s new generation oral antibiotic Miqnaf (Nafithromycin) EP News Bureau Jan 3, 2025 Miqnaf is an ultra-short course, once-a-day, 3-day treatment for community-acquired bacterial pneumonia (CABP) including those…
Soft launch of first indigenous antibiotic to combat AMR, Nafithromycin, announced by Dr Jitendra… Press Information Bureau Nov 21, 2024 The development of Nafithromycin represents 14 years of research and an investment of ₹500 crores, with clinical trials spanning…
FDA approves Nabriva’s antibiotic for pneumonia EP News Bureau Aug 20, 2019 The drug is also Nabriva's first to be approved by the FDA and is expected to be launched in mid-September
